These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 34445641)

  • 21. Bacteriophages as drivers of bacterial virulence and their potential for biotechnological exploitation.
    Schroven K; Aertsen A; Lavigne R
    FEMS Microbiol Rev; 2021 Jan; 45(1):. PubMed ID: 32897318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metagenome Data on Intestinal Phage-Bacteria Associations Aids the Development of Phage Therapy against Pathobionts.
    Fujimoto K; Kimura Y; Shimohigoshi M; Satoh T; Sato S; Tremmel G; Uematsu M; Kawaguchi Y; Usui Y; Nakano Y; Hayashi T; Kashima K; Yuki Y; Yamaguchi K; Furukawa Y; Kakuta M; Akiyama Y; Yamaguchi R; Crowe SE; Ernst PB; Miyano S; Kiyono H; Imoto S; Uematsu S
    Cell Host Microbe; 2020 Sep; 28(3):380-389.e9. PubMed ID: 32652061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phage therapy administered noninvasively could be effective in thin tubes subject to episodic flow despite washout: a simulation study.
    Blanco C; Chen IA
    Phys Biol; 2019 Jul; 16(5):054001. PubMed ID: 31266001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the impact of repeated intravenous phage doses on mammalian host-phage interactions.
    Tan X; Chen K; Jiang Z; Liu Z; Wang S; Ying Y; Zhang J; Yuan S; Huang Z; Gao R; Zhao M; Weng A; Yang Y; Luo H; Zhang D; Ma Y
    J Virol; 2024 Jan; 98(1):e0135923. PubMed ID: 38084959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacteriophage Transcytosis Provides a Mechanism To Cross Epithelial Cell Layers.
    Nguyen S; Baker K; Padman BS; Patwa R; Dunstan RA; Weston TA; Schlosser K; Bailey B; Lithgow T; Lazarou M; Luque A; Rohwer F; Blumberg RS; Barr JJ
    mBio; 2017 Nov; 8(6):. PubMed ID: 29162715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Influence of Bacteriophages on the Metabolic Condition of Human Fibroblasts in Light of the Safety of Phage Therapy in Staphylococcal Skin Infections.
    Kosznik-Kwaśnicka K; Stasiłojć M; Stasiłojć G; Kaźmierczak N; Piechowicz L
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phage-Based Applications in Synthetic Biology.
    Lemire S; Yehl KM; Lu TK
    Annu Rev Virol; 2018 Sep; 5(1):453-476. PubMed ID: 30001182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between the phageome and human health: are bacteriophages beneficial or harmful microbes?
    Fernández L; Duarte AC; Rodríguez A; García P
    Benef Microbes; 2021 Apr; 12(2):107-120. PubMed ID: 33789552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phage Therapy: Going Temperate?
    Monteiro R; Pires DP; Costa AR; Azeredo J
    Trends Microbiol; 2019 Apr; 27(4):368-378. PubMed ID: 30466900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Manufacturing of bacteriophages for therapeutic applications.
    João J; Lampreia J; Prazeres DMF; Azevedo AM
    Biotechnol Adv; 2021; 49():107758. PubMed ID: 33895333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding and Exploiting Phage-Host Interactions.
    Stone E; Campbell K; Grant I; McAuliffe O
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31216787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacteriophages as Biotechnological Tools.
    Elois MA; Silva RD; Pilati GVT; Rodríguez-Lázaro D; Fongaro G
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Back to the future: bacteriophages as promising therapeutic tools.
    Domingo-Calap P; Georgel P; Bahram S
    HLA; 2016 Mar; 87(3):133-40. PubMed ID: 26891965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of phages, bacteria, and the human immune system: Evolutionary changes in phage therapy.
    Jariah ROA; Hakim MS
    Rev Med Virol; 2019 Sep; 29(5):e2055. PubMed ID: 31145517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temperate Bacteriophages-The Powerful Indirect Modulators of Eukaryotic Cells and Immune Functions.
    Cieślik M; Bagińska N; Jończyk-Matysiak E; Węgrzyn A; Węgrzyn G; Górski A
    Viruses; 2021 May; 13(6):. PubMed ID: 34071422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity of bacteriophages.
    Champagne-Jorgensen K; Luong T; Darby T; Roach DR
    Trends Microbiol; 2023 Oct; 31(10):1058-1071. PubMed ID: 37198061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacteriophages benefit from generalized transduction.
    Fillol-Salom A; Alsaadi A; Sousa JAM; Zhong L; Foster KR; Rocha EPC; Penadés JR; Ingmer H; Haaber J
    PLoS Pathog; 2019 Jul; 15(7):e1007888. PubMed ID: 31276485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bacteriophages in the battle against multidrug resistant bacteria].
    van der Meer JWM; Vandenbroucke-Grauls CMJE
    Ned Tijdschr Geneeskd; 2018; 162():D2433. PubMed ID: 29600928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delivering phage therapy per os: benefits and barriers.
    Zelasko S; Gorski A; Dabrowska K
    Expert Rev Anti Infect Ther; 2017 Feb; 15(2):167-179. PubMed ID: 27885865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flagellotropic Bacteriophages: Opportunities and Challenges for Antimicrobial Applications.
    Esteves NC; Scharf BE
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.